This study is evaluating whether a new radioactive chemical may help doctors better understand how the brain works.
1 Primary · 1 Secondary · Reporting Duration: 48 hours post-scan
Experimental Treatment
40 Total Participants · 2 Treatment Groups
Primary Treatment: [11C]-NOP46 · No Placebo Group · Phase < 1
Age 18 - 90 · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: